Delivery Order SPE2DB22D3501-SPE2DB25FVQ02
Award Date
5/8/25
Potential Completion Date
5/9/25
Potential Value
$23K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $30,036.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,568,190,593 units of the pharmaceutical product Ondansetron ODT 4 mg Tablet 30s. The contract has a firm fixed price and an ultimate completion date of May 9, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there are no set-aside designations...
This federal contract award, valued at $1,228.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB22D2006|SPE2DB25FW0LP) for the supply of 4,568,092 units of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of May 1, 2025 and is a firm fixed-price arrangement. This award is not associated with a set-aside program and is part of a...
This federal contract award is an order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,975,143 units of Ondansetron ODT 4 mg tablets in 30-count packages, with a total ceiling value of $22,944.52. The contract is a Firm Fixed Price Delivery Order with a period of performance extending to January 21, 2025. This order is placed under AmerisourceBergen's...
This federal contract award, valued at $4,050.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,201,970 units of Ondansetron ODT 4 mg tablets in packages of 30. This is a firm fixed-price delivery order contract with a performance period extending until May 12, 2025. The contract is not designated as a set-aside and is an open competition award....
This federal contract award, valued at $9,996.23, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,134,913 units of Ondansetron ODT 4 mg Tablets in 30-count packages. This award is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as a primary vehicle for...
This federal contract award, valued at $1,498.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,911,741 units of Ondansetron ODT 4 mg Tablets in packages of 30. This is a firm-fixed-price delivery order contract with a completion date of January 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $37,982.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for 4,568,178,340 units of the medication Ondansetron ODT 8 mg tablets, with a completion date of May 8, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,647.51 firm fixed-price delivery order is for 4,565,192,644 units of the drug Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of July 19, 2024. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any major subcontractors. This award is...
This federal contract award, valued at $6,699.43, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, the prime contractor, for the delivery of 4,564,128,973 units of Ondansetron ODT 8 mg Tablets. The contract is a firm fixed price delivery order with an ultimate completion date of April 2, 2024. AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distributor AmerisourceBergen Corporation, is the prime contractor on an indefinite delivery...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,908.68, is for the delivery of 4,566,615,580 units of 4 mg Ondansetron HCL tablets. The contract is a firm fixed-price delivery order, without any set-aside designation, and has an ultimate completion date of December 5, 2024. Amerisourcebergen holds a larger Indefinite...